InsidersTradesSigma
Track the 한국비엔씨 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 한국비엔씨 has published 42 reports. The latest transaction was disclosed on 13 July 2026 (Other). Among the most active insiders: 최완규. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 42 declarations
한국비엔씨 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.